Clinical Trial Update: DAAOI-2 add-on Treatment for Treatment-resistant Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for DAAOI-2 as add-on treatment in treatment-resistant schizophrenia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• DAAOI-2

Snippet

Sponsor: China Medical University Hospital | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED